99 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
.
Research and Development (R&D) Expenses: For the quarter ended March 31, 2024, R&D expenses were $32.4 million, compared to $37.8 million for the same … :
Research and development
In process research and development
General and administrative
Total operating expenses
Loss from operations
Other income
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
), with 31 affiliates worldwide, and counts more than 7,000 employees. The Group’s research and development centre in Parma works alongside 6 other important
8-K
EX-99.1
ben4ugl8nf2aga591ryp
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
8-K
EX-99.1
wzh5woxah8 luapi0
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
424B3
to491yd9yit db
28 Aug 23
Prospectus supplement
4:29pm
S-3
bjwotz5zn
18 Aug 23
Shelf registration
8:41am
S-3ASR
u7yqfbsrectnmp2
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
81dxhue
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
y85 iirjd
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
EX-99.1
4g4caq38 w0j36ihytw
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
PRE 14A
ak7qlc7h2ngh5gtq
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.1
yxq 3nloei
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm